With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...

A copper-based agent complex kills cancer cells in a novel way. It receives its activation signal through light. It could help where existing chemotherapy treatments reach their limits. Cuproptosis ...

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and a healthy one, then selectively destroy the tumor cell while leaving normal ...